121 related articles for article (PubMed ID: 10550559)
1. Intracellular expression of CD61 precedes surface expression.
Käfer G; Willer A; Ludwig W; Krämer A; Hehlmann R; Hastka J
Ann Hematol; 1999 Oct; 78(10):472-4. PubMed ID: 10550559
[TBL] [Abstract][Full Text] [Related]
2. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?
Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE
Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
Marinov J; Koubek K; Starý J
Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
[TBL] [Abstract][Full Text] [Related]
7. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
10. Lymphoid-associated antigen expression by acute myeloid leukemia.
Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
[TBL] [Abstract][Full Text] [Related]
11. Interleukins and colony stimulating factors in human myeloid leukemia cell lines.
Hassan HT; Drexler HG
Leuk Lymphoma; 1995 Dec; 20(1-2):1-15. PubMed ID: 8750618
[TBL] [Abstract][Full Text] [Related]
12. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
14. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
Cetin N; Lorsbach RB
Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
[TBL] [Abstract][Full Text] [Related]
15. Cytochemical profile of megakaryoblastic leukaemia: a study with cytochemical methods, monoclonal antibodies, and ultrastructural cytochemistry.
Pombo De Oliveira MS; Gregory C; Matutes E; Parreira A; Catovsky D
J Clin Pathol; 1987 Jun; 40(6):663-9. PubMed ID: 3038965
[TBL] [Abstract][Full Text] [Related]
16. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of a cell line established from a case of acute megakaryoblastic leukemia.
Skinnider LF; Pabello P; Zheng CY
Acta Haematol; 1997; 98(1):26-31. PubMed ID: 9210910
[TBL] [Abstract][Full Text] [Related]
18. Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog*.
Valentini F; Tasca S; Gavazza A; Lubas G
Vet Comp Oncol; 2012 Dec; 10(4):312-8. PubMed ID: 22235968
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
20. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
